Showing 1 - 20 results of 189 for search '"therapeutics"', query time: 0.12s Refine Results
  1. 1

    mRNA-Based Therapeutics in Cancer Treatment by Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu

    Published 2023-02-01
    “…Over the past two decades, significant technological innovations have led to messenger RNA (mRNA) becoming a promising option for developing prophylactic and therapeutic vaccines, protein replacement therapies, and genome engineering. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4

    Focus on Mitochondrial Respiratory Chain: Potential Therapeutic Target for Chronic Renal Failure by Yi Wang, Jing Yang, Yu Zhang, Jianhua Zhou

    Published 2024-01-01
    “…This review integrated research related to the mitochondrial respiratory chain and chronic kidney failure, primarily elucidating the pathological status of the mitochondrial respiratory chain in chronic kidney failure and potential therapeutic drugs. It provided new ideas for the treatment of kidney failure and promoted the development of drugs targeting the mitochondrial respiratory chain.…”
    Get full text
    Article
  5. 5

    Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failure by Yu Zhang, Jiayu Yao, Mingming Zhang, Yushan Wang, Xingjuan Shi

    Published 2023-01-01
    “…Elucidating these issues may provide important insights into therapeutic intervention of heart failure.…”
    Get full text
    Article
  6. 6

    Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma by Yang Liu, Li-Yan Yang, Ding-Xiong Chen, Chen Chang, Qing Yuan, Yu Zhang, Yan Cai, Wen-Qiang Wei, Jia-Jie Hao, Ming-Rong Wang

    Published 2024-04-01
    “…Purpose: To establish a prognostic model of esophageal squamous cell carcinoma (ESCC) patients based on tenascin-C (TNC) expression level and clinicopathological characteristics, and to explore the therapeutic potential of TNC inhibition. Methods: The expression of TNC was detected using immunohistochemistry (IHC) in 326 ESCC specimens and 50 normal esophageal tissues. …”
    Get full text
    Article
  7. 7

    PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma by Fei Song, Cheng-Gui Wang, Jia-Zhen Mao, Tian-Lun Wang, Xiao-Liang Liang, Chen-Wei Hu, Yu Zhang, Lu Han, Zhong Chen

    Published 2023-06-01
    “…Our findings underscore the role of YWHAB in Sorafenib resistance, presenting valuable insights for personalized therapeutic strategy development in HCC.…”
    Get full text
    Article
  8. 8

    Understanding Hyperuricemia: Pathogenesis, Potential Therapeutic Role of Bioactive Peptides, and Assessing Bioactive Peptide Advantages and Challenges by Yanchao Chen, Jing Yang, Qinchun Rao, Chen Wang, Xiaoyong Chen, Yu Zhang, Huayi Suo, Jiajia Song

    Published 2023-12-01
    “…Protein peptides derived from food offer advantages such as a wide range of sources, significant therapeutic benefits, and minimal adverse effects. However, they also face challenges in terms of commercialization. …”
    Get full text
    Article
  9. 9
  10. 10

    A Novel 3D Printing Particulate Manufacturing Technology for Encapsulation of Protein Therapeutics: Sprayed Multi Adsorbed-Droplet Reposing Technology (SMART) by Niloofar Heshmati Aghda, Yu Zhang, Jiawei Wang, Anqi Lu, Amit Raviraj Pillai, Mohammed Maniruzzaman

    Published 2022-11-01
    “…This method is based on an additive manufacturing technology that allows for the designing and production of personalized particulate based therapeutic formulations with a precise control over the shape, size, and potentially the geometry. …”
    Get full text
    Article
  11. 11

    A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer by Jia Li, Yinbin Zhang, Chaofan Li, Huizi Wu, Cong Feng, Weiwei Wang, Xuan Liu, Yu Zhang, Yifan Cai, Yiwei Jia, Hao Qiao, Fei Wu, Shuqun Zhang

    Published 2022-10-01
    “…Increasing evidence shows that lactate and long non-coding RNA (lncRNA) play a critical role in tumor occurrence, maintenance, therapeutic response, and immune microenvironment. We aimed to construct a lactate-related lncRNAs prognostic signature (LRLPS) for BC patients to predict prognosis, tumor microenvironment, and treatment responses. …”
    Get full text
    Article
  12. 12
  13. 13
  14. 14

    A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing by Yu Zhang, Hui Li, Takahiko Nishiyama, John R. McAnally, Efrain Sanchez-Ortiz, Jian Huang, Pradeep P.A. Mammen, Rhonda Bassel-Duby, Eric N. Olson

    Published 2022-09-01
    “…This unique DMD mouse model with the human genomic sequence allows in vivo assessment of clinically relevant gene editing strategies as well as other therapeutic approaches and represents a significant step toward therapeutic translation of CRISPR-Cas9 gene editing for correction of DMD.…”
    Get full text
    Article
  15. 15
  16. 16
  17. 17

    A diagnostic model for sepsis-induced acute lung injury using a consensus machine learning approach and its therapeutic implications by Yongxin Zheng, Jinping Wang, Zhaoyi Ling, Jiamei Zhang, Yuan Zeng, Ke Wang, Yu Zhang, Lingbo Nong, Ling Sang, Yonghao Xu, Xiaoqing Liu, Yimin Li, Yongbo Huang

    Published 2023-09-01
    “…The diagnostic model could identify septic patients at high risk of ALI, and provide potential therapeutic targets for sepsis-induced ALI.…”
    Get full text
    Article
  18. 18
  19. 19
  20. 20